Novel Nano Delivery System to Treat Lung Cancer - UCLA/California NanoSystems Institute
Lung cancer is the leading cause of cancer-related deaths worldwide and, therefore, is a major health issue both in developed and less developed countries. Lung cancer is diagnosed at an advanced stage in a majority of patients which is the primary reason behind the high mortality rate associated with this disease. This grant was provided in 2013 to UCLA/California NanoSystems Institute researchers to develop a nano-technology drug delivery system to treat patients with lung cancer. While this constitutes a novel approach, the scientific background behind the plan as well as preliminary results are very promising. A world-class team of scientists and physicians spanning expertise in cancer biology, cell and molecular biology, oncology and nanotechnology has been assembled to participate in this research activity. The project represents a new and optimized approach to biomarker-directed, personalized cancer therapy.
For more information, visit www.ucla.edu